Assessing the viral fitness of oseltamivir-resistant influenza viruses in ferrets, using a competitive-mixtures model.

Journal of Virology
Aeron C HurtIan G Barr

Abstract

To determine the relative fitness of oseltamivir-resistant strains compared to susceptible wild-type viruses, we combined mathematical modeling and statistical techniques with a novel in vivo "competitive-mixtures" experimental model. Ferrets were coinfected with either pure populations (100% susceptible wild-type or 100% oseltamivir-resistant mutant virus) or mixed populations of wild-type and oseltamivir-resistant influenza viruses (80%:20%, 50%:50%, and 20%:80%) at equivalent infectivity titers, and the changes in the relative proportions of those two viruses were monitored over the course of the infection during within-host and over host-to-host transmission events in a ferret contact model. Coinfection of ferrets with mixtures of an oseltamivir-resistant R292K mutant A(H3N2) virus and a R292 oseltamivir-susceptible wild-type virus demonstrated that the R292K mutant virus was rapidly outgrown by the R292 wild-type virus in artificially infected donor ferrets and did not transmit to any of the recipient ferrets. The competitive-mixtures model was also used to investigate the fitness of the seasonal A(H1N1) oseltamivir-resistant H274Y mutant and showed that within infected ferrets the H274Y mutant virus was marginally outgrow...Continue Reading

References

Jan 1, 1988·Reviews of Infectious Diseases·H Smith, C Sweet
Oct 21, 1998·The Journal of Infectious Diseases·L V GubarevaR G Webster
Aug 10, 2000·Antiviral Research·J L McKimm-Breschkin
Feb 27, 2001·The Pediatric Infectious Disease Journal·R J WhitleyP Ward
Oct 13, 2004·The Journal of Infectious Diseases·M Louise HerlocherArnold S Monto
Sep 29, 2005·Antimicrobial Agents and Chemotherapy·Hui-Ling YenElena A Govorkova
Dec 5, 2006·Expert Review of Anti-infective Therapy·Aeron C HurtIan Barr
Jan 27, 2007·PLoS Medicine·Marc LipsitchBruce R Levin
May 16, 2008·Nature·Patrick J CollinsSteven J Gamblin
Mar 4, 2009·JAMA : the Journal of the American Medical Association·Nila J DharanUNKNOWN Oseltamivir-Resistance Working Group
Apr 1, 2009·Emerging Infectious Diseases·Adam MeijerUNKNOWN European Influenza Surveillance Scheme
Aug 4, 2009·The Medical Journal of Australia·James M McCawJodie McVernon
Oct 1, 2009·Emerging Infectious Diseases·Nancy A GerloffClaude P Muller
Dec 17, 2009·The New England Journal of Medicine·Quynh Mai LeUNKNOWN Vietnam H1N1 Investigation Team
Apr 1, 2010·Australian and New Zealand Journal of Public Health·Jodie McVernonTerence M Nolan

❮ Previous
Next ❯

Citations

Nov 1, 2013·Nature Communications·Sophie A ValkenburgKatherine Kedzierska
Aug 17, 2011·Antimicrobial Agents and Chemotherapy·Mitsutaka KitanoKazumasa Ogasawara
Mar 6, 2013·Antimicrobial Agents and Chemotherapy·Jenna E Achenbach, Richard A Bowen
Mar 10, 2012·PloS One·Sinthujan JegaskandaAmy Sexton
May 15, 2013·PLoS Pathogens·Teagan GuarnacciaKaren L Laurie
Aug 24, 2013·Emerging Infectious Diseases·Katrina SleemanLarisa V Gubareva
Apr 9, 2014·Journal of Immunological Methods·Rajagowthamee R Thangavel, Nicole M Bouvier
Nov 27, 2015·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·Karen LittleAeron C Hurt
Sep 4, 2015·ELife·Michael G BuhnerkempeJames O Lloyd-Smith
Jun 14, 2015·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Masatoki SatoMitsuaki Hosoya
Jul 19, 2015·Journal of Theoretical Biology·Stephen M PetrieJames M McCaw
May 29, 2014·Current Opinion in Virology·Aeron C Hurt
Jul 15, 2016·Microbiology and Molecular Biology Reviews : MMBR·Jessica A BelserTaronna R Maines
Oct 27, 2018·Expert Opinion on Drug Discovery·Edin J MifsudAeron C Hurt
Sep 12, 2018·Antimicrobial Agents and Chemotherapy·R FarrukeeA C Hurt
Feb 24, 2011·Expert Review of Anti-infective Therapy·Ben Berkhout, Dirk Eggink
Jul 7, 2018·Clinical Microbiology Reviews·Naveen KumarBarry T Rouse
May 11, 2021·PLoS Pathogens·Andrew R WargoBenjamin Kerr
Aug 24, 2021·Antimicrobial Agents and Chemotherapy·Philippe Noriel Q PascuaElena A Govorkova
Nov 24, 2021·Journal of Molecular Modeling·Mohammad VakiliSilvia Antonia Brandán

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.